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correlation between the prosthesis and this type of lymphoma. Surgical management seems to be essential for diagnosis and
treatment. Given the lack of data, treatment decisions need to be individualized.
http://dx.doi.org/10.1016/j.rpor.2013.03.334
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Introduction. The etiology lymphomatous is especially rare in this location. In 85% of cases of Hodgkin’s disease (HD) presents with
palpable lymphadenopathy. Most seated in the neck (60–80%), with a percentage epitrochlear <2%. Epitrochlear involvement in
Hodgkin disease is an uncommon event reported rarely in the literature. There is currently no clear consensus on the optimal
treatment technique for HD with epitrochlear involvement. Early-stage favorable HD, it may choose to perform after sequential
treatment with QT-RT or RT exclusive. Clinical case: 43-year-old-man with hypertension treated without other diseases. In
August 2011 have a growth on his left forearm without B symptoms, that after excision biopsy-diagnosed HD with lymphocyte-
predominant presence of adenopathy epitrochlear. It takes up study extension revealed the presence of axillary lymph nodes in
left, infraclavicular, supraclavicular and left submandibular. Diagnosed with HD lymphocyte-predominant E-IIA, chemotherapy
starts with ABDV scheme, receiving a total of 2 cycles and then given external radiotherapy with photons ALE 6 and 18MV in
region of left forearm epitrochlear more margin and cervical areas (Ia-IV), left axillary and supraclavicular fossa for a total of
30Gy. It takes a special locking system to place the forearm up and ensure proper coverage epitrochlear. The patient is being
monitored in the service of Hematology and Radiation Oncology. In PET-CT assessment is objective complete metabolic response
with no signs of tumor viability. Currently, the patient remains in complete response.
Conclusions. Epitrochlear involvement in HD is a rare event, with only limited data available describing this unique presentation,
its treatment, and long term outcome. In this case, since it was a stage HD early favorable, it was decided to chemotherapy and
radiotherapy to 30Gy sequentially, achieving complete tumor response.
http://dx.doi.org/10.1016/j.rpor.2013.03.335
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Introduction. Overall prognosis of patients with early-stage Hodgkin lymphoma is excellent, with 10 year overall survival >80%, but
second tumors remain the most important late effect, mostly breast cancer in female patients, so is of paramount importance
to decrease breast dose delivered in these patients. Traditionally these patients have been treated with APPA 3DRT. PURPOSE:
To evaluate different treatment options adopted in our department in order to better treat large volumes while sparing critical
organs.
Materials and methods. There is growing dosimetric evidence that highly conformal radiotherapy may spare critical organs in
lymphomas involving largemediastinal volumes, reducing radiationdose to lung, heart andbreast. To explore possible dosimetric
advantages of IMRT, 3 different options have been evaluated paying attention to improve conformality and minimizing low
radiation doses: 3DRT MLC, APPA Irregular Surface Compensator IMRT with manual ﬂuence shaping and VMAT.
Results. Decisions about choice of one technique over another were taken depending on the beneﬁcial effect in sparing surround-
ing normal tissue while preserving the precision of dose distribution. Illustrative examples of each option are included together
with the decision criteria.
Conclusions. To show our preliminary experience for lymphoma treatment with modern radiation techniques, initiating an open
debate for better technique choice. VMAT results in superior level of homogeneity and sparing organs at risk but increased low
radiation doses. Longer follow-up is needed to verify possible late toxicities.
http://dx.doi.org/10.1016/j.rpor.2013.03.336
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Introduction. Mycosis fungoides (MF) is the most frequent type of cutaneous T-cell lymphoma (CTCL) and is also frequently treated
withRT.A studyof very low-dose radiotherapy formycosis fungoideswith 8Gy in two fractions showed that the complete response
rate was 92%.
Purpose. To determine in our hospital that low-dose palliative radiotherapy is a useful and effective schedule of treatment.
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Methods and materials. A single patient with stage IV MF with 14 symptomatic plaques and tumors underwent low-dose (8Gy in
two fractions) local radiotherapy.
Results. Complete response has been achieved for all lesions (100%). After a median of 18.1 months of follow-up (39-1 months)
no lesions needed re-irradiation.
Conclusions. In our experience low-dose involved ﬁeld radiotherapy has proved to be a very efﬁcient, tolerable and cost effective
approach as a palliative treatment in CTCL lesions.
http://dx.doi.org/10.1016/j.rpor.2013.03.337
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Introduction.BoneMarrowTransplantwith conventionalmyeloablative conditioninghashighmorbidity andmortality, particularly
in fragile patients. These patients may be candidates for a transplant with a non-myeloablative conditioning regime.
Objectives. Retrospective analysis of the feasibility and toxicity of the treatmentwithTBI to 2Gydosenon-myeloablative allogeneic
bone marrow transplant.
Patients and methods. Retrospective study, non randomised, from 2009 to 2012 in patients treated with TBI with 2Gy as part of
the treatment myeloablative allogeneic bone marrow transplant. Inclusion criteria: (1) 50 years and older and not candidates
to myeloablative standar transplant. (2) Tandem transplant, allotransplantation followed by allogenic autotransplantation in a
short period of time. We recruited 6 women and 4 men, aged 43–56 years old, 2 with acute lymphoblastic leukemia, one with
acute myeloid leukemia, 1 with chronic lymphoblastic leukemia, three with multiple myeloma, 1 with myelodysplastic syndrome
and 1 with aplastic anemia. Scheme Conditioning: 2Gy doses in a single session, premedication with 1mg/kg and ondansetron
8mg prednisone/8h at least ½h before TBI. The technique is similar to myeloablative TBI.
Results. No patient had associated toxicity conditioning, 5 relapses, 2 deaths and 3 are still alive and healthy. One underwent
BMT 2Gy and subsequently with INT 5Gy with implant loss and died.
Conclusion. This is a simple technique, with no conditioning linked toxicity that could be used in patients for whom standard
patterns are not feasible.
http://dx.doi.org/10.1016/j.rpor.2013.03.338
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Introduction. Primary lymphomas of the ocular adnexa (OL) constitute 7% of extranodal lymphomas. The most common symp-
toms are a growing mass followed by pain. Low grade histology is most frequent. Intraocular lymphoma (IOL) represent <1% of
lymphomas and its associated with CNS lesions. Bilateral involvement occurs in almost 80% and usually appears as a refractory
non-speciﬁc uveitis associated with campimetric deﬁcit; its often a high grade histology, being commonly diffuse large B cell
lymphoma.
Objective. To report four cases of OL and IOL and their multidisciplinary treatment.
Cases report. Three cases of OL inwomen between 58 and 90 year-old, one primary and two secondary tomarginal zone and follicle
lymphoma. The diagnosis was made by biopsy of low grade lymphoma. One case of IOL in a 69 year-old man with primary CNS
lymphoma. The diagnosis was made by vitreus aspiration of a diffuse B cell lymphoma. They were presented with a growing
mass vision changes of a non-speciﬁc uveitis of 10–24 months of duration. None of the patients received chemotherapy. In two of
the OL cases a gross total resection was performed followed by radiation therapy to the tumoral bed and the other cases received
irradiation of both orbits, TD: 30Gy/1.8Gy.
Results. All patients, the MRI revealed no residual tumor with complete resolution. The patients are in follow-up, asymptomatic
and free recurrence.
Conclusions. The literature suggest that OL can be treated with radiotherapy, reaching local control >95% with good prognostic.
The IOL treatment establishes initial chemotherapy followed by irradiation, they have worse prognostic; ocular recurrence are
common and most patients developed CNS disease within 14–84 With either 30–36Gy and standard fractionation, has been
associated a lower ocular relapse rate, and the effect on ocular disease control suggests that they have a potential role in survival.
http://dx.doi.org/10.1016/j.rpor.2013.03.339
